These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35941761)

  • 1. Hepatitis C virus, insulin resistance, and diabetes: A review.
    Alzahrani N
    Microbiol Immunol; 2022 Oct; 66(10):453-459. PubMed ID: 35941761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
    Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
    Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose abnormalities in hepatitis C virus infection.
    Huang JF; Yu ML; Dai CY; Chuang WL
    Kaohsiung J Med Sci; 2013 Feb; 29(2):61-8. PubMed ID: 23347806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.
    Antonelli A; Ferrari SM; Giuggioli D; Di Domenicantonio A; Ruffilli I; Corrado A; Fabiani S; Marchi S; Ferri C; Ferrannini E; Fallahi P
    World J Diabetes; 2014 Oct; 5(5):586-600. PubMed ID: 25317237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
    Mihm S
    Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection.
    Poussier A; Lebouvier M; Penfornis A; Di Martino V; Buffier P; Verges B; Hillon P; Petit JM
    Diabet Med; 2008 Oct; 25(10):1237-40. PubMed ID: 19046205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2.
    Jeremiah SS; Moin ASM; Butler AE
    Metabolism; 2024 Jul; 156():155917. PubMed ID: 38642828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of insulin resistance markers in Pakistani patients suffering from HCV-associated type 2 diabetes mellitus.
    Sabir SN; Manzoor S; Parvaiz F; Saalim M; Ghani E
    Acta Virol; 2017; 61(2):197-203. PubMed ID: 28523926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus and type 2 diabetes.
    Negro F; Alaei M
    World J Gastroenterol; 2009 Apr; 15(13):1537-47. PubMed ID: 19340895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis C virus therapy on metabolism and public health.
    Shiffman ML; Gunn NT
    Liver Int; 2017 Jan; 37 Suppl 1():13-18. PubMed ID: 28052632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?
    Vanni E; Bugianesi E; Saracco G
    Dig Liver Dis; 2016 Feb; 48(2):105-11. PubMed ID: 26614641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
    Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection and type 2 diabetes.
    Fallahi P; Ferrari SM; Colaci M; Ruffilli I; Vita R; Azzi A; Ferri C; Antonelli A; Ferrannini E
    Clin Ter; 2013; 164(5):e393-404. PubMed ID: 24217842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
    Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
    Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection among patients with diabetes mellitus in Dammam, Saudi Arabia.
    Ba-Essa EM; Mobarak EI; Al-Daghri NM
    BMC Health Serv Res; 2016 Jul; 16():313. PubMed ID: 27464785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs.
    Singhal A; Agrawal A; Ling J
    J Cell Mol Med; 2018 Apr; 22(4):2071-2085. PubMed ID: 29411512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.